MiMedx Group, Inc.(MDXG)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MDXG MiMedx Group, Inc.

未开盘 11-25 16:00:00 EST

9.09

-0.11

-1.20%

盘后9.09

+0.000.00%

19:07 EST

最高9.32	最低9.09	成交量89.64万
今开9.20	昨收9.20	日振幅2.55%
总市值13.36亿	流通市值9.91亿	总股本1.47亿
成交额820.88万	换手率0.82%	流通股本1.09亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"MDXG","market":"US","secType":"STK","nameCN":"MiMedx Group, Inc.","latestPrice":9.09,"timestamp":1732568400000,"preClose":9.2,"halted":0,"volume":896368,"hourTrading":{"tag":"盘后","latestPrice":9.09,"preClose":9.09,"latestTime":"19:07 EST","volume":29143,"amount":265267.7632,"timestamp":1732579647484},"delay":0,"floatShares":108975825,"shares":146946213,"eps":0.518579,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.11,"latestTime":"11-25 16:00:00 EST","open":9.2,"high":9.32,"low":9.085,"amount":8208754.38856,"amplitude":0.025543,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.518579,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732611600000},"adr":0,"listingDate":1366862400000,"adjPreClose":9.2,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":9.22,"preClose":9.2,"latestTime":"09:29 EST","volume":6794,"amount":62360.502234,"timestamp":1732544999999},"postHourTrading":{"tag":"盘后","latestPrice":9.09,"preClose":9.09,"latestTime":"19:07 EST","volume":29143,"amount":265267.7632,"timestamp":1732579647484},"volumeRatio":0.849656,"impliedVol":0.5746,"impliedVolPercentile":0.3532},"requestUrl":"/m/hq/s/MDXG","defaultTab":"news","newsList":[{"id":"2484311084","title":"Mimedx Group, Inc盘中异动 早盘股价大跌5.95%报8.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484311084","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484311084?lang=zh_cn&edition=full","pubTime":"2024-11-20 22:33","pubTimestamp":1732113209,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日22时33分，Mimedx Group, Inc股票出现异动，股价快速跳水5.95%。截至发稿，该股报8.69美元/股，成交量7.9288万股，换手率0.05%，振幅5.06%。Mimedx Group, Inc股票所在的生物技术行业中，整体涨幅为0.34%。Mimedx Group, Inc公司简介：MiMedx Group Inc开发和销售再生生物材料产品和生物植入物，这些产品和植入物由人类羊膜、出生组织和人类皮肤和骨骼制成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120223329abd23317&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120223329abd23317&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MDXG"],"gpt_icon":0},{"id":"2483139804","title":"Mimedx Group, Inc盘中异动 股价大涨7.50%报8.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483139804","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483139804?lang=zh_cn&edition=full","pubTime":"2024-11-14 22:32","pubTimestamp":1731594754,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日22时32分，Mimedx Group, Inc股票出现波动，股价快速上涨7.50%。截至发稿，该股报8.03美元/股，成交量23.0549万股，换手率0.16%，振幅2.41%。Mimedx Group, Inc股票所在的生物技术行业中，整体跌幅为0.47%。Mimedx Group, Inc公司简介：MiMedx Group Inc开发和销售再生生物材料产品和生物植入物，这些产品和植入物由人类羊膜、出生组织和人类皮肤和骨骼制成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111422323495be2ca6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111422323495be2ca6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4183","BK4139","ELAB","MDXG"],"gpt_icon":0},{"id":"2480983293","title":"Mimedx Group, Inc2024财年第三财季实现净利润7.88百万美元，同比减少7.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480983293","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480983293?lang=zh_cn&edition=full","pubTime":"2024-11-04 00:00","pubTimestamp":1730649656,"startTime":"0","endTime":"0","summary":"11月4日，Mimedx Group, Inc公布财报，公告显示公司2024财年第三财季净利润为7.88百万美元，同比减少7.62%；其中营业收入为84.06百万美元，同比增加2.88%，每股基本收益为0.06美元。从资产负债表来看，Mimedx Group, Inc总负债62.88百万美元，其中短期债务1000000.00美元，资产负债比为0.04，流动比率为0.05。机构评级：截至2024年11月4日，当前有5家机构对Mimedx Group, Inc目标价做出预测，其中目标均价为12.20美元，其中最低目标价为11.00美元，最高目标价为14.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104000148ab9b4f01&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104000148ab9b4f01&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MDXG"],"gpt_icon":0},{"id":"1130569908","title":"异动解读 | MiMedx集团季报数据略超预期 获多数\"买入\"评级 股价大涨9%","url":"https://stock-news.laohu8.com/highlight/detail?id=1130569908","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1130569908?lang=zh_cn&edition=full","pubTime":"2024-10-31 21:35","pubTimestamp":1730381715,"startTime":"0","endTime":"0","summary":"MiMedx集团今日收盘大涨9.31%,引发市场广泛关注。消息面上,该公司近期公布的2024年第三季度业绩报告可能是推动股价上涨的主要利好因素。\n\n根据财报数据,MiMedx集团本季度营收同比增长2.9%至8406万美元,略超分析师此前平均预期的8270万美元。在盈利方面,公司实现调整后每股收益5美分,虽然低于去年同期,但处于分析师预期范围内。\n\n尽管业绩表现平平,但数据却优于市场预期,加之公司获得多数分析师的\"买入\"评级,反映外界对其长期前景保持较为乐观的态度。在公司所处的生物技术和医疗行业整体环境向好的背景下,利好因素集中可能推动了MiMedx集团股价的大幅上涨。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MDXG"],"gpt_icon":0},{"id":"2479835038","title":"Mimedx Group, Inc盘中异动 早盘急速上涨17.40%报6.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479835038","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479835038?lang=zh_cn&edition=full","pubTime":"2024-10-31 21:34","pubTimestamp":1730381643,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日21时34分，Mimedx Group, Inc股票出现波动，股价快速拉升17.40%。截至发稿，该股报6.68美元/股，成交量8.5479万股，换手率0.06%，振幅8.96%。Mimedx Group, Inc股票所在的生物技术行业中，整体跌幅为1.87%。Mimedx Group, Inc公司简介：MiMedx Group Inc开发和销售再生生物材料产品和生物植入物，这些产品和植入物由人类羊膜、出生组织和人类皮肤和骨骼制成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103121340395bd9c5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103121340395bd9c5c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MDXG","BK4139"],"gpt_icon":0},{"id":"1199138593","title":"异动解读 | MiMedx集团公布季度业绩 股价盘前大涨5.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=1199138593","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199138593?lang=zh_cn&edition=full","pubTime":"2024-10-31 20:32","pubTimestamp":1730377937,"startTime":"0","endTime":"0","summary":"MiMedx集团(MDXG)今日盘前大涨5.8%,引发市场广泛关注。公司近期公布了截至9月30日的最新季度业绩报告。\n\n财报数据显示,MiMedx集团本季度营收同比增长2.9%至8406万美元,而分析师此前对营收的平均预期为8270万美元,略低于实际数据。在盈利方面,公司实现调整后每股收益5美分,低于去年同期的6美分,但处于分析师预期范围内。\n\n尽管业绩表现平平,但公司依然获得多数分析师的\"买入\"评级,显示外界对公司长期前景保持乐观态度。此外,公司所处的生物技术和医疗行业整体环境较为利好,有助于带动公司股价上涨。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MDXG"],"gpt_icon":0},{"id":"2479145747","title":"MiMedx 集团公司公布截至 9 月 30 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2479145747","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479145747?lang=zh_cn&edition=full","pubTime":"2024-10-31 10:41","pubTimestamp":1730342468,"startTime":"0","endTime":"0","summary":"   * MiMedx Group Inc   公布的截至9月30日的季度调整后每股收益为5美分，低于去年同期的每股收益6美分。华尔街预期为每股收益 4 美分至 5 美分。* MiMedx Group Inc公布的本季度每股收益为5美分。* 公司报告的季度净收入为788万美元。* MiMedx Group Inc的股价本季度下跌了1.7%，今年迄今为止下跌了33.8%。华尔街对 MiMedx Group Inc 的 12 个月目标价中位数为 12.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"MiMedx 集团公司公布截至 9 月 30 日的季度业绩 - 收益摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MDXG"],"gpt_icon":0},{"id":"2456376221","title":"Mimedx Group, Inc2024财年第二财季实现净利润17.62百万美元，同比增加1368.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456376221","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456376221?lang=zh_cn&edition=full","pubTime":"2024-08-04 00:16","pubTimestamp":1722701815,"startTime":"0","endTime":"0","summary":"8月4日，Mimedx Group, Inc公布财报，公告显示公司2024财年第二财季净利润为17.62百万美元，同比增加1368.33%；其中营业收入为87.21百万美元，同比增加7.32%，每股基本收益为0.12美元。从资产负债表来看，Mimedx Group, Inc总负债62.14百万美元，其中短期债务1000000.00美元，资产负债比为0.04，流动比率为0.04。机构评级：截至2024年8月4日，当前有6家机构对Mimedx Group, Inc目标价做出预测，其中目标均价为12.00美元，其中最低目标价为11.00美元，最高目标价为14.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240804001702957ab1ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240804001702957ab1ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MDXG"],"gpt_icon":0},{"id":"2456045992","title":"Craig-Hallum：维持MiMedx Group(MDXG.US)评级，由买入调整至买入评级, 目标价由14.00美元调整至12.","url":"https://stock-news.laohu8.com/highlight/detail?id=2456045992","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456045992?lang=zh_cn&edition=full","pubTime":"2024-08-02 01:01","pubTimestamp":1722531666,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MDXG","BK4139"],"gpt_icon":0},{"id":"2456343329","title":"Mimedx Group, Inc股价重挫12.75% 市值跌1.22亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456343329","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456343329?lang=zh_cn&edition=full","pubTime":"2024-08-01 21:30","pubTimestamp":1722519024,"startTime":"0","endTime":"0","summary":"北京时间2024年08月01日21时30分，Mimedx Group, Inc股票出现波动，股价大幅跳水12.75%。Mimedx Group, Inc股票所在的生物技术行业中，整体涨幅为0.65%。其相关个股中，Immuneering Corporation、Neurosense Therapeutics Ltd.、Precision Biosciences, Inc.涨幅较大，Immuneering Corporation、Cns Pharmaceuticals, Inc.、Neurosense Therapeutics Ltd.较为活跃，换手率分别为42.73%、36.45%、13.09%，振幅较大的相关个股有Neurosense Therapeutics Ltd.、Calidi Biotherapeutics, Inc.、Tnf Pharmaceuticals, Inc.，振幅分别为4.59%、2.55%、1.97%。Mimedx Group, Inc公司简介：MiMedx Group Inc开发和销售再生生物材料产品和生物植入物，这些产品和植入物由人类羊膜、出生组织和人类皮肤和骨骼制成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801213024af9560a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801213024af9560a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","IMRX","BK4563","MDXG"],"gpt_icon":0},{"id":"2456513195","title":"MiMedx 集团公司公布截至 6 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2456513195","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456513195?lang=zh_cn&edition=full","pubTime":"2024-08-01 05:03","pubTimestamp":1722459790,"startTime":"0","endTime":"0","summary":"   * MiMedx Group Inc   公布的截至6月底的季度调整后每股收益为12美分，高于去年同期的每股盈亏平衡收益。七位分析师对该季度的平均预期是每股收益 8 美分。华尔街预期为每股收益 5 美分至 10 美分。* MiMedx Group Inc公布的本季度每股收益为12美分。* 公司报告的季度净收入为1762万美元。* MiMedx Group Inc的股价本季度上涨了9.5%，今年迄今为止下跌了13.5%。华尔街对 MiMedx Group Inc 的 12 个月目标价中位数为 12.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDXG","BK4139"],"gpt_icon":0},{"id":"2455190786","title":"MiMedx Group Inc   预计每股收益8美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2455190786","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455190786?lang=zh_cn&edition=full","pubTime":"2024-07-30 05:06","pubTimestamp":1722287170,"startTime":"0","endTime":"0","summary":"   * MiMedx Group Inc    预计将在7月31日公布截至2024年6月30日的季度收入报告。* 根据LSEG的数据，7位分析师的平均预期显示，这家总部位于佐治亚州玛丽埃塔的公司的营收有望从去年同期的8126万美元增长9.4%，达到8891.9万美元。* LSEG分析师对MiMedx集团公司的平均预期为每股收益8美分。* 华尔街对 MiMedx Group Inc 的 12 个月目标价中位数为 12.00 美元，高于其最新收盘价 7.76 美元。7月29日 - 上一季度业绩。除非另有说明，所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDXG"],"gpt_icon":0},{"id":"2454019058","title":"Mimedx Group, Inc盘中异动 大幅上涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2454019058","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454019058?lang=zh_cn&edition=full","pubTime":"2024-07-26 00:28","pubTimestamp":1721924929,"startTime":"0","endTime":"0","summary":"北京时间2024年07月26日00时28分，Mimedx Group, Inc股票出现波动，股价大幅上涨5.01%。Mimedx Group, Inc股票所在的生物技术行业中，整体涨幅为0.05%。其相关个股中，Salarius Pharmaceuticals, Inc.、Psyence Biomedical Ltd.、Omniab Inc C/Wts 涨幅较大，Salarius Pharmaceuticals, Inc.、Psyence Biomedical Ltd.、Exicure, Inc.较为活跃，换手率分别为4276.31%、549.64%、277.93%，振幅较大的相关个股有Psyence Biomedical Ltd.、Exicure, Inc.、Salarius Pharmaceuticals, Inc.，振幅分别为152.48%、132.26%、98.60%。Mimedx Group, Inc公司简介：MiMedx Group Inc开发和销售再生生物材料产品和生物植入物，这些产品和植入物由人类羊膜、出生组织和人类皮肤和骨骼制成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726002849941faacd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726002849941faacd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MDXG"],"gpt_icon":0},{"id":"2452422929","title":"Mimedx Group, Inc盘中异动 股价大涨5.05%报7.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452422929","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452422929?lang=zh_cn&edition=full","pubTime":"2024-07-17 03:59","pubTimestamp":1721159975,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日03时59分，Mimedx Group, Inc股票出现异动，股价快速拉升5.05%。截至发稿，该股报7.49美元/股，成交量41.4895万股，换手率0.28%，振幅4.21%。Mimedx Group, Inc股票所在的生物技术行业中，整体涨幅为0.32%。Mimedx Group, Inc公司简介：MiMedx Group Inc开发和销售再生生物材料产品和生物植入物，这些产品和植入物由人类羊膜、出生组织和人类皮肤和骨骼制成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407170359359681d46d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407170359359681d46d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MDXG","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.mimedx.com","stockEarnings":[{"period":"1week","weight":-0.0055},{"period":"1month","weight":0.5538},{"period":"3month","weight":0.3836},{"period":"6month","weight":0.2713},{"period":"1year","weight":0.1867},{"period":"ytd","weight":0.0365}],"compareEarnings":[{"period":"1week","weight":0.0159},{"period":"1month","weight":0.0319},{"period":"3month","weight":0.0641},{"period":"6month","weight":0.1358},{"period":"1year","weight":0.3124},{"period":"ytd","weight":0.2571}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"MiMedx Group, Inc.是先进伤口护理行业的领先者，也是一家新兴的治疗性生物制品公司，为多个医疗保健部门开发和销售具有专利保护工艺的胎盘组织。该公司的产品来源于使用其专有加工方法（包括PURION工艺）加工的人体胎盘组织。除了终端灭菌外，公司还采用无菌处理技术来生产公司的同种异体移植物。MiMedx给伤口护理，烧伤，外科，骨科，脊柱，运动医学，眼科和牙科保健部门提供产品。该公司是人类胎盘移植的主要供应商，同种异体胎盘是从一个人（供体）移植到另一个人（接受者）的人体组织。MiMedx已经通过直接和寄售的方式提供了190多万个同种异体移植。","yearOnYearQuotes":[{"month":1,"riseRate":0.363636,"avgChangeRate":0.032322},{"month":2,"riseRate":0.636364,"avgChangeRate":-0.000674},{"month":3,"riseRate":0.454545,"avgChangeRate":-0.05872},{"month":4,"riseRate":0.363636,"avgChangeRate":-0.024177},{"month":5,"riseRate":0.75,"avgChangeRate":0.144923},{"month":6,"riseRate":0.583333,"avgChangeRate":0.075774},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.002178},{"month":8,"riseRate":0.5,"avgChangeRate":0.041056},{"month":9,"riseRate":0.25,"avgChangeRate":-0.106676},{"month":10,"riseRate":0.666667,"avgChangeRate":0.059635},{"month":11,"riseRate":0.833333,"avgChangeRate":0.098274},{"month":12,"riseRate":0.636364,"avgChangeRate":0.030311}],"exchange":"NASDAQ","name":"MiMedx Group, Inc.","nameEN":"MiMedx Group, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"MiMedx Group, Inc.(MDXG)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供MiMedx Group, Inc.(MDXG)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"MiMedx Group, Inc.,MDXG,MiMedx Group, Inc.股票,MiMedx Group, Inc.股票老虎,MiMedx Group, Inc.股票老虎国际,MiMedx Group, Inc.行情,MiMedx Group, Inc.股票行情,MiMedx Group, Inc.股价,MiMedx Group, Inc.股市,MiMedx Group, Inc.股票价格,MiMedx Group, Inc.股票交易,MiMedx Group, Inc.股票购买,MiMedx Group, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"MiMedx Group, Inc.(MDXG)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供MiMedx Group, Inc.(MDXG)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}